BioSpace News Archive

Catalent, Inc. announced that John Chiminski, Chair & Chief Executive Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at 9:30 a.m.

January is Cervical Health Awareness Month. In honor of this important national health awareness observance, Alameda Health System (AHS) and Alameda Alliance for Health (Alliance) are teaming up to encourage more than 10,000 women in Alameda County to come in for their annual cervical screening at any AHS Women’s Wellness Center.

World’s leading life sciences accelerator expands to New York City, beginning April 2020

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with New England Biolabs (NEB®), a global leader in the discovery and production of enzymes for molecular biology applications, granting NEB rights to sell CRISPR/Cas9 tools and reagents

ClinOne is pleased to announce that Ray Collia has joined ClinOne as our EMEA Senior Director of Business Development.

Franciosi Consulting Ltd. (“FCL”) is pleased to announce that its President and CEO, Dr. Luigi Franciosi, has been retained as a pharmacology consultant to advise Vicenna Pharmaceuticals Inc., a new private drug discovery company in Vancouver, British Columbia, on their preclinical and clinical development programs targeting patients with asthma and Chronic Obstructive Pulmonary Disease (COPD).

New IP Protection Creates Barriers to Entry and Supports the Company’s Business Opportunities

Genomic Testing Cooperative, LCA announced that the Medicare Administrative Contractor Palmetto GBA has established coverage for its solid tumor molecular profile.

An oral, gut-restricted IL-23 receptor antagonist peptide is successfully nominated as a second-generation development candidate, advancing the collaboration and triggering a $5M milestone payment

Caladrius Biosciences, Inc. announced that the Company will present at the following conferences in January